Difamilast
Drug profile
Also known as: MM36, moizerto, OPA-15406
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Difamilast is an onp drug catalogued in DrugCentral. It was first approved by the PMDA in 2021. DrugCentral lists 1 molecular target, including PDE4B. Recorded indications include Atopic dermatitis.
- Approval status: onp (first approved 2021 by the PMDA).
- Molecular targets: PDE4B (1 listed in DrugCentral).
- Indications: Atopic dermatitis.
- Molecular formula: C23H24F2N2O5; molecular weight 446.45 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Atopic dermatitis
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE4B | inhibitor | IC50 7.95 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2021-09-27 | PMDA | — | OTSUKA PHARMACEUTICAL Co., Ltd |
Chemical structure
| Molecular formula | C23H24F2N2O5 |
|---|---|
| Molecular weight | 446.45 g/mol |
| CAS number | 937782-05-3 |
| InChIKey | VFBILHPIHUPBPZ-UHFFFAOYSA-N |
| PubChem CID | 57855696 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Difamilast used for?
DrugCentral lists the following indications for Difamilast: Atopic dermatitis.
How does Difamilast work?
Its molecular targets in DrugCentral include PDE4B (inhibitor).
When was Difamilast first approved?
Difamilast was first approved by the PMDA in 2021.
What is the chemical formula of Difamilast?
Difamilast has the molecular formula C23H24F2N2O5 and a molecular weight of 446.45 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5503 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3989968 — compound record and bioactivity
- PubChem CID 57855696 — chemical identifiers
- DrugBank DB14987 — drug record
- FDA UNII T3U32GLJ0F — substance identity
- UniProt Q07343 (PDE4B) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.